News | Cardiac Resynchronization Therapy Devices (CRT)

Biotronik announced the full commercial launch of the Acticor device family, including Acticor DX and CRT-DX devices. Electrophysiologists throughout the United States are now treating patients with the new implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).

Home April 29, 2019
Home
News | Congenital Heart

Edwards Lifesciences is recalling the Miller Balloon Atrioseptostomy Catheter and Fogarty Dilation Atrioseptostomy Catheter because of the possibility of difficulty in balloon deflation after deployment, which may lead to balloon fragmentation or detachment upon attempted retrieval. The firm has received reports of balloon fragmentation or detachment, which may cause serious adverse health consequences including: damage to the heart, the inferior vena cava, and/or the femoral and iliac veins; additional procedures to retrieve the fragments; permanent patient disability; pulmonary embolism; stroke; damage to other organs; or death. One serious injury was reported in which an infant underwent an invasive, but successful surgical procedure to retrieve a detached balloon. There were no deaths reported.

Home April 29, 2019
Home
News | Ultrasound Imaging

With healthcare costs continuing to rise, affordable and accurate imaging and diagnosis achieved through ultrasound will continue to attract patients, according to a new market report from Fact.MR. The report on the global market for ultrasound systems projects steady growth for the market from 2017 to 2022, from a value of $6 billion in 2017 to $7.8 billion toward the end of 2022 — a compound annual growth rate (CAGR) of 5.5 percent.

Home April 26, 2019
Home
Technology | EP Mapping and Imaging Systems

Acutus Medical announced U.S. Food and Drug Administration (FDA) clearance of its second-generation AcQMap platform, along with CE Mark approval for its AcQMap contact mapping software.

Home April 26, 2019
Home
News | Medical 3-D Printing

April 26, 2019 — A 72-year-old woman from northern Michigan became Henry Ford Health System’s 1,000th patient treated ...

Home April 26, 2019
Home
Videos | Structural Heart

Dee Dee Wang, M.D., director of structural heart imaging, Henry Ford Hospital, Detroit, Mich., explains how patient ...

Home April 25, 2019
Home
Videos | Left Atrial Appendage (LAA) Occluders

This video offers an overview of the Watchman left atrial appendage (LAA) occluder system, including information of its ...

Home April 25, 2019
Home
News | Womens Cardiovascular Health

The thickness of the coronary artery wall as measured by magnetic resonance imaging (MRI) is an independent marker for heart disease in women, according to a study published in the journal Radiology: Cardiothoracic Imaging.

Home April 25, 2019
Home
News | Stroke

Stroke patients examined remotely by a teleneurologist were treated as quickly and effectively after hours as during normal business hours, according to new research by The University of Texas Health Science Center at Houston (UTHealth).

Home April 24, 2019
Home
News | Antiplatelet and Anticoagulation Therapies

April 24, 2019 — New research from the University of Illinois at Chicago shows that when pharmacies close, people stop ...

Home April 24, 2019
Home
Figure 1: A computed tomography angiography (CTA) study performed for transcatheter aortic valve replacement planning.  Interventional imagers created and interpret these images as part of the heart team.
Feature | Structural Heart | Nadeen N. Faza, M.D., Dee Dee Wang, M.D., Joao Cavalcante, M.D., Andrew D. Choi, M.D., Jeffrey B. Geske, M.D., and Stephen H. Little, M.D.

Recent months have signaled a new and exciting era in the dynamic world of structural heart disease (SHD). The COAPT ...

Home April 24, 2019
Home
Technology | Drug-Eluting Balloons

Orchestra BioMed Inc. has secured Breakthrough Device designation by the U.S. Food and Drug Administration (FDA) for its Virtue Sirolimus-Eluting Balloon for the treatment of coronary in-stent restenosis (ISR).

Home April 24, 2019
Home
Boston Scientific Receives FDA Approval for Lotus Edge Aortic Valve System
Feature | Heart Valve Technology | Dave Fornell, Editor

Boston Scientific Corp. announced it has received U.S. Food and Drug Administration (FDA) approval for the Lotus Edge Aortic Valve System. Delivered via a minimally invasive procedure, this transcatheter aortic valve replacement (TAVR) technology is approved for patients with severe aortic stenosis who are considered at high risk for surgical valve replacement via open heart surgery.

Home April 23, 2019
Home
News | Cath Lab

Determining which elderly heart attack patients take longer to stand from a seated position and walk across a room may help predict who will be readmitted to the hospital within a month, according to new research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

Home April 23, 2019
Home
News | Heart Valve Technology

April 22, 2019 — Five cardiovascular professional societies released a new consensus document on optimizing care for ...

Home April 22, 2019
Home
Subscribe Now